THROMBIN HUMAN AND FIBRINOGEN

THROMBIN HUMAN AND FIBRINOGEN was reported 336 times

THROMBIN HUMAN AND FIBRINOGEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION SITE CALCIFICATION 2 0.2222
1 FAILED BACK SURGERY SYNDROME 2 0.0909
2 ANTI FACTOR V ANTIBODY POSITIVE 3 0.0732
3 ANTI FACTOR VII ANTIBODY POSITIVE 1 0.0667
4 PENILE PLAQUE 2 0.0667
5 SCAN WITH CONTRAST ABNORMAL 1 0.0556
6 CARDIAC PSEUDOANEURYSM 3 0.0435
7 PSEUDOMENINGOCELE 6 0.0382
8 PULMONARY FISTULA 3 0.0309
9 PANCREATIC FISTULA 4 0.0260
10 DURAL TEAR 2 0.0256
11 SUBDURAL ABSCESS 1 0.0217
12 POST PROCEDURAL PERSISTENT DRAIN FLUID 1 0.0217
13 ALLOIMMUNISATION 1 0.0217
14 PUERPERAL PYREXIA 1 0.0200
15 PULMONARY AIR LEAKAGE 3 0.0199
16 BILIARY FISTULA 3 0.0196
17 COAGULATION FACTOR XIII LEVEL DECREASED 1 0.0192
18 INTERVENTRICULAR SEPTUM RUPTURE 1 0.0179
19 POST PROCEDURAL BILE LEAK 5 0.0160
20 CONDUCTIVE DEAFNESS 5 0.0156
21 URETHRAL FISTULA 1 0.0149
22 ANAL HYPOAESTHESIA 1 0.0147
23 PULMONARY PNEUMATOCELE 1 0.0141
24 INTERVENTIONAL PROCEDURE 1 0.0135
25 ABSCESS STERILE 2 0.0135
26 DRAIN REMOVAL 1 0.0135
27 OVARIAN ADHESION 1 0.0125
28 ATONIC URINARY BLADDER 2 0.0103
29 POSTOPERATIVE THORACIC PROCEDURE COMPLICATION 1 0.0103
30 COAGULATION FACTOR V LEVEL DECREASED 3 0.0092
31 MENINGITIS CHEMICAL 2 0.0091
32 PNEUMOCEPHALUS 3 0.0091
33 LYMPHOCELE 6 0.0090
34 LARYNGEAL HAEMORRHAGE 1 0.0087
35 PENILE CURVATURE 2 0.0085
36 CEREBROSPINAL FLUID LEAKAGE 15 0.0081
37 SUPERIOR VENA CAVA OCCLUSION 1 0.0079
38 HEPATITIS C ANTIBODY POSITIVE 2 0.0074
39 APPLICATION SITE NODULE 1 0.0073
40 REPERFUSION INJURY 1 0.0072
41 LOCALISED INTRAABDOMINAL FLUID COLLECTION 3 0.0067
42 PERIPANCREATIC FLUID COLLECTION 1 0.0066
43 SUBDURAL HYGROMA 2 0.0066
44 CAUDA EQUINA SYNDROME 5 0.0065
45 TONSIL CANCER 5 0.0062
46 SURGICAL PROCEDURE REPEATED 4 0.0058
47 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0055
48 APPLICATION SITE HAEMATOMA 1 0.0055
49 FACTOR V INHIBITION 1 0.0052
50 PLEURAL ADHESION 1 0.0050
51 ANAL SPHINCTER ATONY 2 0.0047
52 PERIRENAL HAEMATOMA 1 0.0046
53 FOREIGN BODY REACTION 1 0.0041
54 INTESTINAL ANASTOMOSIS COMPLICATION 1 0.0037
55 INCISION SITE PAIN 4 0.0034
56 POST PROCEDURAL PNEUMONIA 1 0.0033
57 GASTRIC HYPOMOTILITY 1 0.0033
58 VENOUS HAEMORRHAGE 1 0.0032
59 PROCEDURAL VOMITING 2 0.0031
60 INFLAMMATION OF WOUND 1 0.0030
61 PELVIC NEOPLASM 1 0.0029
62 VASCULAR PSEUDOANEURYSM 5 0.0029
63 SUTURE RELATED COMPLICATION 2 0.0028
64 MENINGITIS BACTERIAL 4 0.0028
65 CHYLOTHORAX 2 0.0028
66 HEPATITIS B VIRUS TEST POSITIVE 1 0.0026
67 BRAIN COMPRESSION 1 0.0025
68 BONE ABSCESS 1 0.0025
69 UTERINE MASS 1 0.0024
70 APPARENT LIFE THREATENING EVENT 1 0.0024
71 CITROBACTER INFECTION 1 0.0023
72 ABDOMINAL ABSCESS 10 0.0023
73 PERINEAL ABSCESS 1 0.0022
74 LIVER ABSCESS 7 0.0022
75 MENINGISM 1 0.0021
76 SUBCUTANEOUS EMPHYSEMA 2 0.0020
77 INFECTIOUS PLEURAL EFFUSION 3 0.0020
78 SPLENIC HAEMORRHAGE 1 0.0020
79 APPLICATION SITE INFECTION 1 0.0020
80 KELOID SCAR 1 0.0019
81 FAECAL CALPROTECTIN INCREASED 6 0.0019
82 MEDIASTINITIS 1 0.0017
83 GRAFT COMPLICATION 1 0.0017
84 SUPERIOR VENA CAVA SYNDROME 1 0.0017
85 BLOOD BILIRUBIN DECREASED 1 0.0016
86 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
87 TRACHEO-OESOPHAGEAL FISTULA 1 0.0016
88 PERITONEAL DISORDER 1 0.0015
89 INTRACRANIAL HYPOTENSION 1 0.0015
90 HIV TEST POSITIVE 1 0.0015
91 INTESTINAL DILATATION 2 0.0015
92 RENAL VEIN THROMBOSIS 1 0.0015
93 POST PROCEDURAL DISCHARGE 1 0.0015
94 SUTURE RUPTURE 1 0.0014
95 ANASTOMOTIC LEAK 1 0.0014
96 ARTERIAL INJURY 1 0.0013
97 ADHESION 2 0.0013
98 PROCEDURAL HAEMORRHAGE 5 0.0013
99 EXTRADURAL ABSCESS 1 0.0013
100 HEPATITIS E 2 0.0013
101 PROCEDURAL NAUSEA 1 0.0012
102 ENTEROCOCCAL SEPSIS 1 0.0012
103 INCISION SITE COMPLICATION 1 0.0012
104 HEPATIC HAEMORRHAGE 1 0.0012
105 POUCHITIS 1 0.0012
106 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
107 VOCAL CORD PARALYSIS 2 0.0011
108 MUSCLE NECROSIS 1 0.0011
109 OVARIAN DISORDER 1 0.0011
110 MEDICATION RESIDUE PRESENT 5 0.0010
111 PARAPLEGIA 3 0.0010
112 POSTOPERATIVE WOUND INFECTION 7 0.0010
113 HAEMOTHORAX 3 0.0010
114 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
115 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
116 POST PROCEDURAL HAEMORRHAGE 11 0.0009
117 PERICARDIAL HAEMORRHAGE 2 0.0009
118 MENINGITIS ASEPTIC 4 0.0009
119 AORTIC THROMBOSIS 1 0.0009
120 HYPOCHLORAEMIA 1 0.0009
121 RECTAL ULCER 1 0.0009
122 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
123 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
124 SUBCUTANEOUS HAEMATOMA 1 0.0008
125 HEPATIC INFECTION 1 0.0008
126 MEDICATION RESIDUE 2 0.0008
127 IATROGENIC INJURY 1 0.0008
128 APPETITE DISORDER 5 0.0008
129 PERITONEAL HAEMORRHAGE 1 0.0007
130 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
131 EOSINOPHILIC PNEUMONIA 2 0.0006
132 PORTAL VEIN THROMBOSIS 2 0.0006
133 WOUND COMPLICATION 2 0.0006
134 GRANULOMA 2 0.0006
135 HYPERREFLEXIA 2 0.0006
136 JUGULAR VEIN THROMBOSIS 1 0.0006
137 MONOPARESIS 1 0.0006
138 VENOUS OCCLUSION 1 0.0005
139 WOUND HAEMORRHAGE 2 0.0005
140 SMALL INTESTINAL PERFORATION 1 0.0005
141 LOSS OF CONTROL OF LEGS 2 0.0005
142 HEPATIC MASS 1 0.0005
143 TRAUMATIC LUNG INJURY 1 0.0005
144 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
145 DIPLEGIA 1 0.0005
146 SENSORY LOSS 4 0.0005
147 EAR HAEMORRHAGE 1 0.0005
148 RENAL HAEMORRHAGE 1 0.0005
149 SUBILEUS 1 0.0005
150 BRAIN OEDEMA 6 0.0005
151 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
152 NEUROGENIC BLADDER 1 0.0005
153 PURULENT DISCHARGE 2 0.0005
154 MONOPLEGIA 2 0.0005
155 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
156 LARGE INTESTINE PERFORATION 3 0.0004
157 CARDIAC TAMPONADE 2 0.0004
158 SYSTEMIC CANDIDA 1 0.0004
159 ABDOMINAL INFECTION 1 0.0004
160 PROCEDURAL COMPLICATION 3 0.0004
161 INCREASED BRONCHIAL SECRETION 1 0.0004
162 PNEUMOTHORAX 6 0.0004
163 ABDOMINAL RIGIDITY 1 0.0004
164 SHOCK HAEMORRHAGIC 3 0.0004
165 HYDROCEPHALUS 2 0.0004
166 WOUND INFECTION 4 0.0004
167 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
168 FIBROSIS 1 0.0003
169 BLOOD CREATININE DECREASED 1 0.0003
170 ABDOMINAL ADHESIONS 1 0.0003
171 POST PROCEDURAL COMPLICATION 6 0.0003
172 ATELECTASIS 3 0.0003
173 HAEMATOMA 8 0.0003
174 PRODUCT ADHESION ISSUE 11 0.0003
175 HYPOVENTILATION 1 0.0003
176 CYTOLYTIC HEPATITIS 1 0.0003
177 CIRCULATORY COLLAPSE 5 0.0003
178 INTESTINAL OBSTRUCTION 11 0.0003
179 GRAFT VERSUS HOST DISEASE 2 0.0003
180 VENTRICULAR ARRHYTHMIA 1 0.0003
181 THROMBOCYTOSIS 1 0.0003
182 AMYLASE INCREASED 1 0.0003
183 PROTEIN TOTAL DECREASED 1 0.0003
184 HYPOALBUMINAEMIA 2 0.0003
185 SPINAL CORD COMPRESSION 1 0.0003
186 FOREIGN BODY 1 0.0002
187 HEPATITIS C 3 0.0002
188 ABNORMAL FAECES 2 0.0002
189 EXTRAVASATION 1 0.0002
190 ILEUS 3 0.0002
191 HEPATIC LESION 1 0.0002
192 URINE OUTPUT DECREASED 2 0.0002
193 SARS-COV-2 TEST POSITIVE 3 0.0002
194 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
195 LEUKOCYTOSIS 4 0.0002
196 INFLAMMATORY BOWEL DISEASE 2 0.0002
197 BODY TEMPERATURE DECREASED 2 0.0002
198 APPLICATION SITE BURN 1 0.0002
199 STAPHYLOCOCCAL SEPSIS 1 0.0002
200 HAEMATOCRIT DECREASED 4 0.0002
201 KLEBSIELLA INFECTION 1 0.0002
202 DRUG LEVEL DECREASED 2 0.0002
203 ENDOCARDITIS 1 0.0002
204 ANAPHYLACTIC SHOCK 5 0.0002
205 POOR VENOUS ACCESS 2 0.0002
206 FOETAL DEATH 1 0.0002
207 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
208 SCIATICA 3 0.0002
209 FREQUENT BOWEL MOVEMENTS 5 0.0002
210 RASH MACULO-PAPULAR 4 0.0002
211 NECROSIS 1 0.0002
212 INTRACRANIAL PRESSURE INCREASED 1 0.0002
213 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
214 FISTULA 2 0.0002
215 COLECTOMY 1 0.0002
216 PERIORBITAL SWELLING 1 0.0002
217 CAESAREAN SECTION 2 0.0002
218 PROTHROMBIN TIME PROLONGED 1 0.0002
219 LARYNGEAL OEDEMA 1 0.0002
220 CHOLANGITIS 1 0.0002
221 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
222 URINARY RETENTION 5 0.0001
223 MENINGITIS 1 0.0001
224 DEFAECATION URGENCY 1 0.0001
225 APPLICATION SITE REACTION 1 0.0001
226 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
227 DUODENAL ULCER 1 0.0001
228 RED BLOOD CELL COUNT DECREASED 4 0.0001
229 C-REACTIVE PROTEIN INCREASED 5 0.0001
230 HEPATOCELLULAR CARCINOMA 1 0.0001
231 HAEMODYNAMIC INSTABILITY 1 0.0001
232 SHOCK 3 0.0001
233 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
234 PULMONARY HAEMORRHAGE 1 0.0001
235 BLOOD ALBUMIN DECREASED 1 0.0001
236 ABSCESS 2 0.0001
237 POST PROCEDURAL INFECTION 1 0.0001
238 ASPHYXIA 1 0.0001
239 HYPERAESTHESIA 1 0.0001
240 ESCHERICHIA INFECTION 1 0.0001
241 EMBOLISM 1 0.0001
242 HEMIPARESIS 2 0.0001
243 SKIN SWELLING 1 0.0001
244 FACIAL PAIN 1 0.0001
245 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
246 THERAPY NON-RESPONDER 5 0.0001
247 ANAL INCONTINENCE 1 0.0001
248 HEPATIC FUNCTION ABNORMAL 4 0.0001
249 SPINAL DISORDER 1 0.0001
250 BRAIN INJURY 1 0.0001
251 TOXIC SKIN ERUPTION 1 0.0001
252 PLEURAL EFFUSION 6 0.0001
253 NERVOUS SYSTEM DISORDER 3 0.0001
254 TENDERNESS 1 0.0001
255 RHINORRHOEA 6 0.0001
256 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
257 MUSCLE TWITCHING 2 0.0001
258 DELIRIUM 3 0.0001
259 BACTERAEMIA 1 0.0001
260 ERECTILE DYSFUNCTION 2 0.0001
261 BLOOD BILIRUBIN INCREASED 2 0.0001
262 IMPAIRED GASTRIC EMPTYING 1 0.0001
263 PROCEDURAL PAIN 2 0.0001
264 BLOOD TEST ABNORMAL 1 0.0001
265 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
266 BRONCHOSPASM 1 0.0001
267 PARALYSIS 1 0.0001
268 CARDIOGENIC SHOCK 1 0.0001
269 DYSSTASIA 2 0.0001
270 ASCITES 2 0.0001
271 PULMONARY OEDEMA 3 0.0001
272 DEVICE FAILURE 1 0.0001
273 DEVICE ADHESION ISSUE 1 0.0001
274 DEVICE RELATED INFECTION 1 0.0001
275 PRODUCT USE COMPLAINT 1 0.0001
276 SEPSIS 7 0.0001
277 SENSORY DISTURBANCE 1 0.0001
278 MUSCLE TIGHTNESS 1 0.0001
279 IMPAIRED HEALING 2 0.0001
280 COAGULOPATHY 1 0.0001
281 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
282 FACE OEDEMA 1 0.0001
283 INFLAMMATION 3 0.0001
284 MULTI-ORGAN FAILURE 1 0.0001
285 HYPOXIA 2 0.0001
286 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
287 ISCHAEMIC STROKE 1 0.0001
288 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
289 RESPIRATORY FAILURE 4 0.0001
290 RESTLESSNESS 2 0.0001
291 HAEMATOCHEZIA 3 0.0001
292 HYPOCALCAEMIA 1 0.0001
293 PULMONARY FIBROSIS 1 0.0001
294 ATRIAL FIBRILLATION 5 0.0001
295 PREGNANCY 1 0.0000
296 THROMBOSIS 4 0.0000
297 OFF LABEL USE 43 0.0000
298 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
299 PERITONITIS 1 0.0000
300 RENAL FAILURE ACUTE 2 0.0000
301 EATING DISORDER 1 0.0000
302 BLOOD PRESSURE DECREASED 3 0.0000
303 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
304 PANCREATITIS ACUTE 1 0.0000
305 PRODUCT QUALITY ISSUE 6 0.0000
306 PERICARDIAL EFFUSION 1 0.0000
307 PULMONARY EMBOLISM 4 0.0000
308 DISEASE RECURRENCE 2 0.0000
309 URTICARIA 7 0.0000
310 INFECTION 6 0.0000
311 INTERSTITIAL LUNG DISEASE 2 0.0000
312 CEREBRAL INFARCTION 1 0.0000
313 HEART RATE INCREASED 4 0.0000
314 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
315 HAEMATEMESIS 1 0.0000
316 CARDIOVASCULAR DISORDER 1 0.0000
317 HAEMOGLOBIN DECREASED 4 0.0000
318 HAEMORRHAGE 4 0.0000
319 GASTRITIS 1 0.0000
320 PLATELET COUNT DECREASED 4 0.0000
321 OEDEMA 2 0.0000
322 CARDIAC ARREST 3 0.0000
323 WOUND 1 0.0000
324 ABDOMINAL PAIN 8 0.0000
325 SURGERY 2 0.0000
326 RESPIRATORY DISORDER 1 0.0000
327 PREMATURE BABY 1 0.0000
328 HEPATIC FAILURE 1 0.0000
329 APHASIA 1 0.0000
330 CONSTIPATION 7 0.0000
331 SWOLLEN TONGUE 1 0.0000
332 PYREXIA 11 0.0000
333 ANAEMIA 6 0.0000
334 CYSTITIS 1 0.0000
335 HYPOTHYROIDISM 1 0.0000
336 DEEP VEIN THROMBOSIS 2 0.0000
337 SWELLING FACE 2 0.0000
338 STAPHYLOCOCCAL INFECTION 1 0.0000
339 RENAL FAILURE 4 0.0000
340 VISUAL ACUITY REDUCED 1 0.0000
341 EXPIRED PRODUCT ADMINISTERED 1 0.0000
342 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
343 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
344 MOBILITY DECREASED 2 0.0000
345 MUSCULAR WEAKNESS 3 0.0000
346 BLOOD PRESSURE INCREASED 4 0.0000
347 CARDIAC FAILURE 2 0.0000
348 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
349 RECTAL HAEMORRHAGE 1 0.0000
350 SEPTIC SHOCK 1 0.0000
351 ANGIOEDEMA 1 0.0000
352 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
353 COLITIS ULCERATIVE 1 0.0000
354 ADVERSE EVENT 2 0.0000
355 HYPOKALAEMIA 1 0.0000
356 PNEUMONIA 7 0.0000
357 PRODUCT USE ISSUE 4 0.0000
358 DRUG INEFFECTIVE 28 0.0000
359 LUNG DISORDER 1 0.0000
360 ABDOMINAL DISTENSION 2 0.0000
361 PARAESTHESIA 3 0.0000
362 HYPERTENSION 4 0.0000
363 BRADYCARDIA 1 0.0000
364 DRUG EFFECT DECREASED 1 0.0000
365 ANAPHYLACTIC REACTION 1 0.0000
366 PANCYTOPENIA 1 0.0000
367 HYPONATRAEMIA 1 0.0000
368 LETHARGY 1 0.0000
369 SEIZURE 2 0.0000
370 COVID-19 3 0.0000
371 DYSPHONIA 1 0.0000
372 FEELING HOT 1 0.0000
373 HYPERSENSITIVITY 3 0.0000
374 EXPOSURE DURING PREGNANCY 1 0.0000
375 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
376 ANXIETY 4 0.0000
377 MALAISE 6 0.0000
378 EPISTAXIS 1 0.0000
379 HYPOAESTHESIA 2 0.0000
380 ACUTE KIDNEY INJURY 2 0.0000
381 VOMITING 6 0.0000
382 HEADACHE 8 0.0000
383 NAUSEA 10 0.0000
384 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
385 TREATMENT FAILURE 1 0.0000
386 DIARRHOEA 7 0.0000
387 SWELLING 1 0.0000
388 DYSPHAGIA 1 0.0000
389 GAIT DISTURBANCE 2 0.0000
390 PAIN IN EXTREMITY 3 0.0000
391 DIZZINESS 5 0.0000
392 HYPOTENSION 2 0.0000
393 FLUSHING 1 0.0000
394 ERYTHEMA 2 0.0000
395 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
396 THROMBOCYTOPENIA 1 0.0000
397 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
398 DECREASED APPETITE 2 0.0000
399 CHILLS 1 0.0000
400 VISUAL IMPAIRMENT 1 0.0000
401 INSOMNIA 2 0.0000
402 CEREBROVASCULAR ACCIDENT 1 0.0000
403 URINARY TRACT INFECTION 1 0.0000
404 NO ADVERSE EVENT 1 0.0000
405 PAIN 3 0.0000
406 ABDOMINAL PAIN UPPER 1 0.0000
407 WEIGHT INCREASED 1 0.0000
408 BACK PAIN 1 0.0000
409 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
410 WEIGHT DECREASED 1 0.0000
411 COUGH 1 0.0000
412 DYSPNOEA 2 0.0000
413 DEATH 3 0.0000
414 CONDITION AGGRAVATED 1 0.0000
415 FALL 1 0.0000
416 ASTHENIA 1 0.0000
417 PRURITUS 1 0.0000
418 FATIGUE 2 0.0000